Cresco Labs (CSE: CL) announced that they will be reporting their second quarter financials before the market opens on August 13.
Analysts have a consensus C$23.31 12-month price target on the company, via a total of 17 analysts, with 5 analysts having a strong buy rating, 11 analysts have a buy rating and a single analyst has a hold rating. The street high comes in at a C$36 price target, and the lowest target comes in at a C$13.66 price target.
13 analysts have revenue estimates for the second quarter. The mean between all 13 is $194.72 million; this number has been the same since the start of the year. The street high is $216.20 million while the lowest sits at $187 million.
8 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 50.65%, with this number being revised slightly higher from 49.25% at the start of the year. Street high goes to Beacon Securities with a 52% estimate and the lowest sits at 50%.
Onto EBITDA estimates, there are currently 131analysts who have second quarter EBITDA estimates. The mean is currently $44.56 million, with this number being lower than at the start of the year. Street high goes to ATB Capital Markets with a $47.30 million EBITDA estimate and the lowest being a $40.99 million estimate.
Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
